# Arcus Biosciences, Inc.: Form 8-K, filed Nov 18, 2021

- Company: [Arcus Biosciences, Inc.](/companies/rcus.md) (CIK 1724521)
- Form: 8-K
- Filed: 2021-11-18
- Accepted by EDGAR: Nov 18, 2021, 07:06 ET
- Period: 2021-11-17
- Accession: 0000950170-21-004749
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1724521/000095017021004749/rcus-20211117.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1724521/000095017021004749/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1724521/000095017021004749/rcus-20211117.htm

Filed Nov 18, 2021.
Source: SEC EDGAR, the filing index for accession 0000950170-21-004749. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
